79 Results

People

  1. Levine
    Levine
  2. Stein
    Stein
  3. Thompson
    Thompson
  4. Abdel-Wahab
    Abdel-Wahab
  5. Harding
    Harding
  6. Tallman
    Tallman
  7. Abou-Alfa
    Abou-Alfa
  8. Jarnagin
    Jarnagin
  9. Mellinghoff
    Mellinghoff
  10. Rampal
    Rampal

Groups

  1. Department of Medicine (47)
  2. Center for Hematologic Malignancies (42)
  3. GSK Faculty (40)
  4. Hematologic Malignancies, Division of (36)
  5. Adult Leukemia (30)
  6. Human Oncology and Pathogenesis Program (28)
  7. Executive Committee, Center for Hematologic Malignancies (20)
  8. Sloan Kettering Institute Postdocs (18)
  9. Tow Center for Developmental Oncology (TCDO) (18)
  10. Department of Pathology and Laboratory Medicine (16)
  1. "isocitrate dehydrogenase 1"
Formats
  1. Journal Article (64)
  2. Review (7)
  3. Meeting Abstract (4)
  4. Editorial (2)
  5. Correspondence (1)
  6. Research Letter (1)
Groups
  1. Department of Medicine (47)
  2. Center for Hematologic Malignancies (42)
  3. GSK Faculty (40)
  4. Hematologic Malignancies, Division of (36)
  5. Adult Leukemia (30)
  6. Human Oncology and Pathogenesis Program (28)

More Groups

People
  1. Ross Levine (15)
  2. Eytan Stein (13)
  3. Craig Thompson (9)
  4. James Harding (7)
  5. Omar Abdel-Wahab (7)
  6. Martin Tallman (6)

More People

Years
  1. 2025 (4)
  2. 2024 (9)
  3. 2023 (8)
  4. 2022 (2)
  5. 2021 (3)
  6. 2020 (12)

More Years

Publications
  1. Cancer Cell (4)
  2. Neuro-Oncology (4)
  3. Blood Advances (3)
  4. Brain Pathology (3)
  5. Cancer Discovery (3)
  6. Nature Genetics (3)

More Publications

Publishers
  1. Nature Publishing Group (11)
  2. Elsevier Inc. (10)
  3. Springer (9)
  4. Cell Press (6)
  5. American Association for Cancer Research (5)
  6. American Society of Hematology (5)

More Publishers

Results (79)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Demethylation and epigenetic modification with 5-azacytidine reduces IDH1 mutant glioma growth in combination with temozolomide
    Journal Article

    Yamashita, A. S.; da Costa Rosa, M.; Borodovsky, A.; Festuccia, W. T.; Chan, T.; Riggins, G. J.
    Neuro-Oncology (2019)

    Fulltext@MSK | Save
  • The molecular landscape of glioma in patients with neurofibromatosis 1
    Journal Article

    D’Angelo, F.; Ceccarelli, M.; Tala; Garofano, L.; Zhang, J.; Frattini, V.; Caruso, F. P.; Lewis, G.; Alfaro, K. D.; Bauchet, L.; more...
    Nature Medicine (2019)

    Fulltext@MSK | Save
  • Isoform switching as a mechanism of acquired resistance to mutant isocitrate dehydrogenase inhibition
    Journal Article

    Harding, J. J.; Lowery, M. A.; Shih, A. H.; Schvartzman, J. M.; Hou, S.; Famulare, C.; Patel, M.; Roshal, M.; Do, R. K.; Zehir, A.; more...
    Cancer Discovery (2018)

    Fulltext@MSK | Save
  • JAK2/IDH-mutant–driven myeloproliferative neoplasm is sensitive to combined targeted inhibition
    Journal Article

    McKenney, A. S.; Lau, A. N.; Hanasoge Somasundara, A. V.; Spitzer, B.; Intlekofer, A. M.; Ahn, J.; Shank, K.; Rapaport, F. T.; Patel, M. A.; Papalexi, E.; more...
    Journal of Clinical Investigation (2018)

    Fulltext@MSK | Save
  • Mutant-IDH1-dependent chromatin state reprogramming, reversibility, and persistence
    Journal Article

    Turcan, S.; Makarov, V.; Taranda, J.; Wang, Y.; Fabius, A. W. M.; Wu, W.; Zheng, Y.; El-Amine, N.; Haddock, S.; Nanjangud, G.; more...
    Nature Genetics (2018)

    Fulltext@MSK | Save
  • Targeted differentiation therapy with mutant IDH inhibitors: Early experiences and parallels with other differentiation agents
    Journal Article

    Stein, E.; Yen, K.
    Annual Review of Cancer Biology (2017)

    Fulltext@MSK | Save
  • In vivo imaging of glutamine metabolism to the oncometabolite 2-hydroxyglutarate in IDH1/2 mutant tumors
    Journal Article

    Salamanca-Cardona, L.; Shah, H.; Poot, A. J.; Correa, F. M.; Di Gialleonardo, V.; Lui, H.; Miloushev, V. Z.; Granlund, K. L.; Tee, S. S.; Cross, J. R.; more...
    Cell Metabolism (2017)

    Fulltext@MSK | Save
  • Low-grade astrocytoma mutations in IDH1, P53, and ATRX cooperate to block differentiation of human neural stem cells via repression of SOX2
    Journal Article

    Modrek, A. S.; Golub, D.; Khan, T.; Bready, D.; Prado, J.; Bowman, C.; Deng, J.; Zhang, G.; Rocha, P. P.; Raviram, R.; more...
    Cell Reports (2017)

    Fulltext@MSK | Save
  • Targeting IDH mutations in acute myeloid leukemia
    Meeting Abstract

    Tallman, M. S.; Stein, E. M.; Coombs, C. C.; Levine, R. L.
    Annals of Hematology (2017)

    Fulltext@MSK | Save
  • Molecularly targeted therapies for acute myeloid leukemia
    Journal Article

    Stein, E. M.
    Hematology-American Society of Hematology Education Program (2015)

    Fulltext@MSK | Save